APR 20 - APR 21
2018
FRI - SAT

Stanford Cancer Immunotherapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Immunotherapy

Frances C. Arrillaga Alumni Center, McCaw Hall, Stanford CA

A Continuing Medical Education Conference presented by the Department of Medicine and the Division of Blood and Marrow Transplant at the Stanford University School of Medicine.

Statement of Need

This CME activity seeks to fulfill the need in the transplant and cellular therapeutics community to increase and improve knowledge as well as management skillset in performing stem cell transplantation and cellular therapeutics to optimize patients’ clinical outcomes. The conference will utilize lectures, debate and panel discussion to achieve the educational objectives.

Target Audience

This national conference is designed to meet the educational needs of:

  • Physicians practicing in hematology, oncology, and internal medicine
  • Physicians Assistants
  • Nurse  Practitioners
  • Nurses

Learning Objectives

At the conclusion of this activity, learners will be able to:

  • Review the difference of transplant-related mortality/morbidity and chance of disease relapse in myeloablative regimen, in reduced intensity regimen and in non-myeloablative regimen in order to determine the best treatment options for your patients presenting with myelodysplastic syndrome.
  • Utilize Stanford guidelines on the criteria for ICU transfer of critically ill post-transplant patients.
  • Determine the different pathways involved in the pathogenesis of Graft-Versus-Host Disease (GVHD) and use them as a guide for choosing different classes of treatment in individual patients.
  • Analyze the pros and cons of different donor sources based on current clinical data in order to determine which sources to use with your patients.
  • Review the application of high-throughput sequencing (HTS) to monitor minimal residual disease after transplant and in managing disease relapse.
  • Review the outcome data using CD-19 targeting CAR T-cells from different institutes, and be familiar with the guidelines in managing therapy-related complications.

Course Directors

Course Director

Laura Johnston, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation)
Division of Blood and Marrow Transplant

Course Co-Director

Wen-Kai Weng, M.D., Ph.D.
Associate Professor of Medicine (Blood and Marrow Transplantation)
Division of Blood and Marrow Transplant

A Continuing Medical Education Activity

Presented by the Department of Medicine at the Stanford University School of Medicine.

Sponsored by the Stanford University School of Medicine


Conference Contact

For conference related questions please contact

Yolanda Cervantes
CME Conference Coordinator
(650) 724-9549
ycervant@stanford.edu

For general questions, please send us an email or call us
stanfordcme@stanford.edu
(650) 497-8554

Mailing List

New activities are added regularly.  Join our mailing list to receive notifications about activities of interest to you.